Prostate Cancer Susceptibility Loci: Finding the Genes

  • Elanie A. Ostrander
  • Bo Johannesson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 617)

In 2006 alone, nearly 234,460 men in the USA will be diagnosed with prostate cancer (PC). In addition, about 27,000 will die from, rather than with, their disease (1). Although there is considerable variability in disease incidence by age, race, and family history, about 70% of all cases are ≥65 years (yrs) at diagnosis, and the median age at diagnosis in the USA is 68 yrs (2). The disease is more frequent among African American (AA) than Caucasians; Asian men have the lowest reported incidence (3, 4).


Prostate Cancer Gleason Score Prostate Cancer Case Jewish Family Prostate Cancer Susceptibility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jemal A, Siegel R, Ward E, et al. (2006) Cancer Statistics, 2006. CA Cancer J Clin, 56: 106–130.PubMedCrossRefGoogle Scholar
  2. 2.
    Ries L, Harkins D, Krapcho M, et al. (2005) SEER Cancer Statistics Review, 1975–2003. Bethesda MD: National Cancer Institute.Google Scholar
  3. 3.
    Wingo PA, Bolden S, Tong T, et al. (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin, 46: 113–125.PubMedCrossRefGoogle Scholar
  4. 4.
    Walker B, Figgs LH, Zahm S (1995) Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect, 103: 275–182.PubMedCrossRefGoogle Scholar
  5. 5.
    Carter BS, Beaty TH, Steinberg GD, et al. (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA, 89: 3367–3371.PubMedCrossRefGoogle Scholar
  6. 6.
    Schaid DJ, McDonnell SK, Blute ML, et al. (1998) Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet, 62: 1425–1438.PubMedCrossRefGoogle Scholar
  7. 7.
    Grönberg H, Damber L, Damber, JE, et al. (1997) Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidemiol, 146: 552–557.PubMedGoogle Scholar
  8. 8.
    Cui J, Staples MP, Hopper JL, et al. (2001) Segregation analyses of 1, 476 population-based australian families affected by prostate cancer. Am J Hum Genet, 68: 1207–1218.PubMedCrossRefGoogle Scholar
  9. 9.
    Stanford JL, Ostrander EA (2001) Familial prostate cancer. Epidemiol Rev, 23: 19–23.PubMedGoogle Scholar
  10. 10.
    Steinberg GD, Carter BS, Beaty TH, et al. (1990) Family history and the risk of prostate cancer. Prostate, 17: 337–347.PubMedCrossRefGoogle Scholar
  11. 11.
    Cannon L, Bishop DT, Skolnick M, et al. (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv, 1: 47–69.Google Scholar
  12. 12.
    Page WF, Braun MM, Partin AW, et al. (1997) Heredity and prostate cancer: a study of World War II veteran twins. Prostate, 33: 240–245.PubMedCrossRefGoogle Scholar
  13. 13.
    Lichtenstein P, Holm NV, Verkasalo PK, et al. (2000) Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland [see comments]. N Engl J Med, 343: 78–85.PubMedCrossRefGoogle Scholar
  14. 14.
    Smith JR, Freije D, Carpten JD, et al. (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science, 274: 1371–1374.PubMedCrossRefGoogle Scholar
  15. 15.
    Suarez BK, Lin J, Burmester JK, et al. (2000) A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet, 66: 933–944.PubMedCrossRefGoogle Scholar
  16. 16.
    Gibbs M, Stanford JL, Jarvik GP, et al. (2000) A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet, 67: 100–109.PubMedCrossRefGoogle Scholar
  17. 17.
    Suarez BK, Lin J, Witte JS, et al. (2000) Replication linkage study for prostate cancer susceptibility genes. Prostate, 45: 106–114.PubMedCrossRefGoogle Scholar
  18. 18.
    Goddard KA, Witte JS, Suarez BK, et al. (2001) M. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet, 68: 1197–1206.PubMedCrossRefGoogle Scholar
  19. 19.
    Cunningham JM, McDonnell SK, Marks A, et al. (2003) Genome linkage screen for prostate cancer susceptiblity loci: Results from the Mayo Clinic Familial Prostate Cancer Study. Prostate, 57: 335–346.PubMedCrossRefGoogle Scholar
  20. 20.
    Edwards S, Meitz J, Eles R, et al. (2003) Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate, 57: 270–279.PubMedCrossRefGoogle Scholar
  21. 21.
    Janer M, Friedrichsen DM, Stanford JL, et al. (2003) Genomic scan of 254 hereditary prostate cancer families. Prostate, 57: 309–319.PubMedCrossRefGoogle Scholar
  22. 22.
    Lange EM, Gillanders EM, Davis CC, et al. (2003) Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate, 57: 326–334.PubMedCrossRefGoogle Scholar
  23. 23.
    Schleutker J, Baffoe-Bonnie AB, Gillanders E, et al. (2003) Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25–26. Prostate, 57: 280–289.PubMedCrossRefGoogle Scholar
  24. 24.
    Wiklund F, Jonsson BA, Goransson I, et al. (2003) Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22–23. Hum Genet, 112: 414–418.PubMedGoogle Scholar
  25. 25.
    Xu J, Gillanders EM, Wiley KE, et al. (2003) Genome-wide scan for prostate cancer susceptilbity genes in the Johns Hopkins Hereditary prostate cancer families. Prostate, 57: 320–325.PubMedCrossRefGoogle Scholar
  26. 26.
    Matsui H, Suzuki K, Ohtake N, et al. (2004) Genomewide linkage analysis of familial prostate cancer in the Japanese population. J Hum Genet, 49: 9–15.PubMedCrossRefGoogle Scholar
  27. 27.
    Hsieh CL, Oakley-Girvan I, Balise RR, et al. (2001) A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet, 69: 148–158.PubMedCrossRefGoogle Scholar
  28. 28.
    Gillanders EM, Xu J, Chang BL, et al. (2004) Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst, 96: 1240–1247.PubMedCrossRefGoogle Scholar
  29. 29.
    Camp NJ, Farnham JM, Cannon Albright LA (2005) Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65: 365–374.PubMedCrossRefGoogle Scholar
  30. 30.
    Xu J, Dimitrov L, Chang BL, et al. (2005) A combined genomewide linkage scan of 1, 233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet, 77: 219–229.PubMedCrossRefGoogle Scholar
  31. 31.
    Ostrander EA, Stanford JL (2000) Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet, 67: 1367–1375.PubMedCrossRefGoogle Scholar
  32. 32.
    Ostrander EA, Markianos K, Stanford JL (2004) Finding prostate cancer susceptibility genes. Annu Rev Genomics Hum Genet, 5: 151–175.PubMedCrossRefGoogle Scholar
  33. 33.
    Easton DF, Schaid DJ, Whittemore AS, et al. (2003) Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate, 57: 261–269.PubMedCrossRefGoogle Scholar
  34. 34.
    Verhage BA, Kiemeney LA (2003) Inherited predisposition to prostate cancer. Eur J Epidemiol, 18: 1027–1036.PubMedCrossRefGoogle Scholar
  35. 35.
    Schaid DJ (2004) The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13: R103–R121.PubMedCrossRefGoogle Scholar
  36. 36.
    Carter BS, Bova GS, Beaty TH, et al. (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol, 150: 797–802.PubMedGoogle Scholar
  37. 37.
    Singh R, Eeles RA, Durocher F, et al. (2000) High risk genes predisposing to prostate cancer development-do they exist? Prostate Cancer Prostatic Dis, 3: 241–247.PubMedCrossRefGoogle Scholar
  38. 38.
    Easton D, Peto J (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surv, 9: 395–416.PubMedGoogle Scholar
  39. 39.
    Nupponen NN, Carpten JD (2001) Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20: 155–164.PubMedCrossRefGoogle Scholar
  40. 40.
    Tavtigian SV, Simard J, Teng DH, et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27: 172–180.PubMedCrossRefGoogle Scholar
  41. 41.
    Carpten J, Nupponen N, Isaacs S, et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet, 30: 181–184.PubMedCrossRefGoogle Scholar
  42. 42.
    Xu J, Zheng SL, Carpten JD, et al. (2001) Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet, 68: 901–911.PubMedCrossRefGoogle Scholar
  43. 43.
    Edwards SM, Kote-Jarai Z, Meitz J, et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet, 72: 1–12.PubMedCrossRefGoogle Scholar
  44. 44.
    Rokman A, Baffoe-Bonnie AB, Gillanders E, et al. (2005) Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet, 116: 43–50.PubMedCrossRefGoogle Scholar
  45. 45.
    Rennert H, Bercovich D, Hubert A, et al. (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet, 71: 981–984.PubMedCrossRefGoogle Scholar
  46. 46.
    Rokman A, Ikonen T, Seppala EH, et al. (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet, 70: 1299–1304.PubMedCrossRefGoogle Scholar
  47. 47.
    Witte JS, Suarez BK, Thiel B, et al. (2003) Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate, 57: 298–308.PubMedCrossRefGoogle Scholar
  48. 48.
    Xu J (2000) ICPCG Combined analysis of hereditary prostate cancer linkage to 1q24–25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet, 66: 945–957.PubMedCrossRefGoogle Scholar
  49. 49.
    Schaid DJ, Chang BL (2005) Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate, 63: 276–290.PubMedCrossRefGoogle Scholar
  50. 50.
    Schaid DJ, McDonnell SK, Zarfas KE, et al. (2006) Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 120:471–85.PubMedCrossRefGoogle Scholar
  51. 51.
    Ostrander EA, Kwon EM, Stanford JL (2006) Genetic susceptibility to aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev, 15: 1761–1764.PubMedCrossRefGoogle Scholar
  52. 52.
    Gleason D (1997) Histologic grading and clinical staging of prostatic carcinoma. Philadelphia: Lea and Febiger.Google Scholar
  53. 53.
    Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol, 23: 273–279.PubMedCrossRefGoogle Scholar
  54. 54.
    Witte JS, Goddard KA, Conti DV, et al. (2000) Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet, 67: 92–99.PubMedCrossRefGoogle Scholar
  55. 55.
    Neville PJ, Conti DV, Paris PL, et al. (2002) Prostate cancer aggressiveness locus on chromosome 7q32–q33 identified by linkage and allelic imbalance studies. Neoplasia, 4: 424–431.PubMedCrossRefGoogle Scholar
  56. 56.
    Neville PJ, Conti DV, Krumroy LM, et al. (2003) Prostate cancer aggressiveness locus on chromosome segment 19q12–q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer, 36: 332–339.PubMedCrossRefGoogle Scholar
  57. 57.
    Paiss T, Worner S, Kurtz F, et al. (2003) Linkage of aggressive prostate cancer to chromosome 7q31–33 in German prostate cancer families. Eur J Hum Genet, 11: 17–22.PubMedCrossRefGoogle Scholar
  58. 58.
    Slager SL, Schaid DJ, Cunningham JM, et al. (2003) Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet, 72: 759–762.PubMedCrossRefGoogle Scholar
  59. 59.
    Slager SL, Zarfas KE, Brown WM, et al. (2006) Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. Prostate, 66: 173–179.PubMedCrossRefGoogle Scholar
  60. 60.
    Chang B, Isaacs S, Wiley K, et al. (2005) Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate, 64: 356–361.PubMedCrossRefGoogle Scholar
  61. 61.
    Stanford JL, McDonnell SK, Friedrichsen DM, et al. (2006) Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate, 66: 317–325.PubMedCrossRefGoogle Scholar
  62. 62.
    Johanneson B, Deutsch K, McIntosh L, et al. Suggestive genetic linkage to chromosome 11q12.1 in hereditary prostate cancer families with primary kidney cancer. Prostate (in press).Google Scholar
  63. 63.
    Gronberg H, Bergh A, Damber JE, et al. (2000) Cancer risk in families with hereditary prostate carcinoma. Cancer, 89: 1315–1321.PubMedCrossRefGoogle Scholar
  64. 64.
    Vaittinen P, Hemminki K (1999) Familial cancer risks in offspring from discordant parental cancers. Int J Cancer, 81: 12–19.PubMedCrossRefGoogle Scholar
  65. 65.
    Amundadottir LT, Sulem P, Gudmundsson J, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet, 38: 652–658.PubMedCrossRefGoogle Scholar
  66. 66.
    Eldon BJ, Jonsson E, Tomasson J, et al. (2003) Familial risk of prostate cancer in Iceland. BJU Int, 92: 915–919.PubMedCrossRefGoogle Scholar
  67. 67.
    Jonsson E, Sigbjarnarson HP, Tomasson J, et al. (2006) Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Scand J Urol Nephrol, 40: 265–271.PubMedCrossRefGoogle Scholar
  68. 68.
    Rokman A, Baffoe-Bonnie AB, Gillanders E, et al. (2005) Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet, 116: 43–50.PubMedCrossRefGoogle Scholar
  69. 69.
    Hamel N, Kotar K, Foulkes WD (2003) Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet, 4: 7.PubMedCrossRefGoogle Scholar
  70. 70.
    Orr-Urtreger A, Bar-Shira A, Bercovich D, et al. (2006) RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomarkers Prev, 15: 474–479.PubMedCrossRefGoogle Scholar
  71. 71.
    Poynter JN, Cooney KA, Bonner JD, et al. (2006) APC I1307K and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15: 468–473.PubMedCrossRefGoogle Scholar
  72. 72.
    Bar-Shira A, Matarasso N, Rosner S, et al. (2006) Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6. Prostate, 66: 1052–1060.PubMedCrossRefGoogle Scholar
  73. 73.
    Dagan E, Laitman Y, Levanon N, et al. (2006) The 471delAAAG Mutation and C353T Polymorphism in the RNASEL Gene in Sporadic and Inherited Cancer in Israel. Fam Cancer, 31: 31.Google Scholar
  74. 74.
    Friedrichsen DM, Stanford JL, Isaacs SD, et al. (2004) Identification of a prostate cancer susceptibility locus on chromosome 7q11–21 in Jewish families. Proc Natl Acad Sci USA, 101: 1939–1944.PubMedCrossRefGoogle Scholar
  75. 75.
    Cook Jr, EH (2002) Merlin: faster linkage analysis with improved genotyping error detection. Pharmacogenomics J, 2: 139–140.CrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Elanie A. Ostrander
    • 1
  • Bo Johannesson
  1. 1.National Human Genome Research InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations